BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) develops in the mucosal linings of the upper aerodigestive tract. HNSCC may develop in large preneoplastic fields, which are in most cases invisible, but can be detected microscopically and by genetic analysis. METHODS: Cells of mucosal tissue biopsies were cultured and genetically analyzed. Genetic changes in established preneoplastic cultures were compared to the corresponding tumor and surgical margins. RESULTS: Of 45 mucosal tissue biopsies taken from primary tumor resection specimen, 26 were successfully cultured and could be genetically analyzed. In 1 culture, genetic changes were found and an immortalized preneoplastic cell line was obtained with genetic changes that were also found in a surgical margin of the corresponding specimen. CONCLUSION: Our data show that noninvasive fields surrounding HNSCC may consist of immortalized preneoplastic cell clones. Our preneoplastic cell line is a valuable tool to develop and test treatment strategies for precursor fields in patients with HNSCC.
BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) develops in the mucosal linings of the upper aerodigestive tract. HNSCC may develop in large preneoplastic fields, which are in most cases invisible, but can be detected microscopically and by genetic analysis. METHODS: Cells of mucosal tissue biopsies were cultured and genetically analyzed. Genetic changes in established preneoplastic cultures were compared to the corresponding tumor and surgical margins. RESULTS: Of 45 mucosal tissue biopsies taken from primary tumor resection specimen, 26 were successfully cultured and could be genetically analyzed. In 1 culture, genetic changes were found and an immortalized preneoplastic cell line was obtained with genetic changes that were also found in a surgical margin of the corresponding specimen. CONCLUSION: Our data show that noninvasive fields surrounding HNSCC may consist of immortalized preneoplastic cell clones. Our preneoplastic cell line is a valuable tool to develop and test treatment strategies for precursor fields in patients with HNSCC.
Authors: D Vicky de Boer; Sanne R Martens-de Kemp; Marijke Buijze; Marijke Stigter-van Walsum; Elisabeth Bloemena; Ralf Dietrich; C René Leemans; Victor W van Beusechem; Boudewijn J M Braakhuis; Ruud H Brakenhoff Journal: Oncotarget Date: 2017-05-16
Authors: Anne M van Harten; Marijke Buijze; Richard van der Mast; Martin A Rooimans; Sanne R Martens-de Kemp; Costa Bachas; Arjen Brink; Marijke Stigter-van Walsum; Rob M F Wolthuis; Ruud H Brakenhoff Journal: Oncogenesis Date: 2019-06-17 Impact factor: 7.485
Authors: Jebrane Bouaoud; Paolo Bossi; Moshe Elkabets; Sandra Schmitz; Léon C van Kempen; Pierre Martinez; Sankar Jagadeeshan; Ingrid Breuskin; Gerwin J Puppels; Caroline Hoffmann; Keith D Hunter; Christian Simon; Jean-Pascal Machiels; Vincent Grégoire; Chloé Bertolus; Ruud H Brakenhoff; Senada Koljenović; Pierre Saintigny Journal: Cancers (Basel) Date: 2022-04-02 Impact factor: 6.639
Authors: David Roulois; Sophie Deshayes; Marie-Noëlle Guilly; Joëlle S Nader; Charly Liddell; Myriam Robard; Philippe Hulin; Amal Ouacher; Vanessa Le Martelot; Jean-François Fonteneau; Marc Grégoire; Christophe Blanquart; Daniel L Pouliquen Journal: Oncotarget Date: 2016-06-07
Authors: Anne M van Harten; D Vicky de Boer; Sanne R Martens-de Kemp; Marijke Buijze; Sonja H Ganzevles; Keith D Hunter; C René Leemans; Victor W van Beusechem; Rob M F Wolthuis; Renée X de Menezes; Ruud H Brakenhoff Journal: Sci Rep Date: 2020-02-11 Impact factor: 4.379